Fractionated Radioimmunotherapy of Non-Hodgkin Lymphoma with 90-Y-Labeled Anti-CD22 Antibody, Epratuzumab Tetraxetan

Kraeber-Bodéré, F., Faivre-Chauvet, A., Bodet-Milin, C., Pallardy, A., Wegener, W. A., Chatal, J.-F., & Goldenberg, D. M. (2012). Fractionated Radioimmunotherapy of Non-Hodgkin Lymphoma with 90-Y-Labeled Anti-CD22 Antibody, Epratuzumab Tetraxetan (pp. 551–556). https://doi.org/10.1007/174_2012_709